CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Endo Pharmaceuticals Inc. v. Impax Laboratories, Inc.

1:12-cv-08317

Overview

Case Number 1:12-cv-08317
Filing Date 2012-11-14
Status Terminated
Termination Date 2016-06-29
Court District Court, S.D. New York (nysd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:1331 Fed. Question: Other
Jury Demand Plaintiff

Parties

Defendant

Endo Pharmaceuticals Inc. Operating Company

Represented By

9 Attorneys Listed

Impax Laboratories, Inc. Operating Company

Represented By

4 Attorneys Listed

Counter Claimant

Thorx Laboratories, Inc. Operating Company

Represented By

4 Attorneys Listed

Counter Defendant

Grunenthal GMBH NPE (Individual / Inventor)

Represented By

4 Attorneys Listed

Court & Judges

Court

District Court, S.D. New York (nysd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 2 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 9 proceedings
🏛️
USPTO PTAB Trials 2 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (2): GB 🇺🇸 US
Parallel Proceedings Across Jurisdictions (11 found):
PTAB: 2 U.S. Courts: 9
USPTO PTAB Trial 2014-01-16
IPR2014-00361

Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2013-11-18
IPR2014-00160

Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals Inc.

U.S. Continuation Sibling (7851482)
Status: Terminated-Settled
U.S. District Court 2016-01-19
1:16-cv-00025

Purdue Pharma L.P. v. Abhai, LLC

U.S. Family Sibling (["US7674799", "US7674800", "US7683072", "US8114383", "US8808741", "US8894987", "US8894988", "US8309060", "US9073933", "US9492389", "US9492391", "US9492392", "US9492393", "US9522919", "US8337888", "US9060976"])
Status: DED
U.S. District Court 2015-12-15
1:15-cv-01152

Purdue Pharma L.P. v. Amneal Pharmaceuticals LLC

U.S. Family Sibling (["US7674799", "US7674800", "US7683072", "US8114383", "US8309060", "US8337888", "US8808741", "US8894987", "US8894988", "US9060976", "US9034376", "US9073933"])
Status: DED
U.S. District Court 2013-05-17
1:13-cv-03374

Purdue Pharma L.P. v. PAR Pharmaceutical, Inc.

U.S. Family Sibling (["US8114383"])
Status: NYSD
U.S. District Court 2013-05-17
1:13-cv-03372

Purdue Pharma L.P. v. Amneal Pharmaceuticals, LLC

U.S. Family Sibling (["US8114383", "US8337888"])
Status: NYSD
U.S. District Court 2013-05-15
1:13-cv-03288

Endo Pharmaceuticals Inc. v. Roxane Laboratories, Inc.

Asserted Patent
Status: NYSD
U.S. District Court 2013-05-10
1:13-cv-03188

Purdue Pharma L.P. v. Impax Laboratories, Inc.

U.S. Family Sibling (["US8114383"])
Status: NYSD
U.S. District Court 2012-12-11
1:12-cv-08985

Endo Pharmaceuticals Inc. v. Actavis Inc.

Asserted Patent
Status: NYSD
U.S. District Court 2012-11-07
1:12-cv-08115

Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals, LLC

Asserted Patent
Status: NYSD
U.S. District Court 2012-11-05
1:12-cv-08060

Endo Pharmaceuticals Inc., and Grunenthal GbmH v. Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc.

Asserted Patent
Status: NYSD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

6 Patents

There are 6 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7851482
Method for making analgesics
Filed: 2007-10-03
Issued: 2010-12-14
Active (2.6 yrs remaining) +646d PTA
Expires: 2029-07-10
US8114383
Abuse-proofed dosage form
Filed: 2003-11-20
Issued: 2012-02-14
Expired (Term Ended) +325d PTA
Expires: 2024-10-10
US8309060
Abuse-proofed dosage form
Filed: 2012-01-09
Issued: 2012-11-13
Active (5.1 yrs remaining)
Expires: 2032-01-09
US8192722
Abuse-proof dosage form
Filed: 2008-06-17
Issued: 2012-06-05
Expired (Term Ended)
Expires: 2025-09-14
US8309122
Oxymorphone controlled release formulations
Filed: 2007-02-28
Issued: 2012-11-13
Expired (Term Ended)
Expires: 2026-03-08

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+646 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

16

Dispositive

1

Granted

4

Denied

0

Pending / Review

12

Motions by Category

Procedural / Extension Motion 10 Claim Construction / Markman Filing 1 Motion for Summary Judgment (Rule 56) 1 Motion to Strike / Sanctions 4

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Rule 56) Pending / Under Review
RULE 56.1 STATEMENT. Document filed by Impax Laboratories, Inc.. (Samay, Scott) (Entered: 02/18/2015)
Entry #98 • 2015-02-18 Document →
Procedural / Extension Motion Pending / Under Review
LETTER addressed to Judge Thomas P. Griesa from Kevin E. Warner dated 10/20/2015 re: Response to Plaintiff's 10/19/2015 letter re: Endo's Motion to Amend the Co...
Entry #180 • 2015-10-20 Document →
Procedural / Extension Motion Pending / Under Review
MOTION to Amend/Correct 155 Clerk's Judgment,,,,, . Document filed by Endo Pharmaceuticals Inc..(Goldberg, Brian) (Entered: 09/21/2015)
Entry #167 • 2015-09-21 Document →
Motion to Strike / Sanctions Pending / Under Review
CLERK'S JUDGMENT: That for the reasons stated in the Court's Findings of Fact and Conclusions of Law dated August 14, 2015, that defendants' generic products, a...
Entry #155 • 2015-08-24 Document →
Motion to Strike / Sanctions Pending / Under Review
FINDINGS OF FACT AND CONCLUSIONS OF LAW: For the reasons given above, the court concludes that defendants' generic products, as described in their ANDAs, infrin...
Entry #154 • 2015-08-18 Document →
Motion to Strike / Sanctions Pending / Under Review
ORDER terminating 105 Motion in Limine; terminating 107 Motion in Limine; terminating 109 Motion in Limine. Because defendant Actavis is already on the market w...
Entry #153 • 2015-08-14 Document →

Docket Entries

(246 total)
Pleading / Complaint

COMPLAINT against Impax Laboratories, Inc., Thorx Laboratories, Inc. (Filing Fee $ 350.00, Receipt Number not indicated)Document filed by Endo Pharmaceuticals Inc., Grunenthal GMBH.(laq) (mqu). (Entered: 11/20/2012)

Entry #1 • 2012-11-14
1
Court Order

STANDING ORDER IN RE PILOT PROJECT REGARDING CASE MANAGEMENT TECHNIQUES FOR COMPLEX CIVIL CASES IN THE SOUTHERN DISTRICT OF NEW YORK (See M-10-468 Order filed November 1, 2011). This case is hereby designated for inclusion in the Pilot Project Regarding Case Management Techniques for Complex Civil Cases in the Southern District of New York (the Pilot Project), unless the judge to whom this case is assigned determines otherwise. This case is designated for inclusion in the Pilot Project because it is a class action, an MDL action, or is in one of the following Nature of Suit categories: 160, 245, 315, 355, 365, 385, 410, 830, 840, 850, 893, or 950. The presiding judge in a case that does not otherwise qualify for inclusion in the Pilot Project may nevertheless designate the case for inclusion in the Pilot Project by issuing an order directing that the case be included in the Pilot Project. The description of the Pilot Project, including procedures to be followed, is attached to this Order. (Signed by Judge Loretta A. Preska on 10/31/2011) (laq) (Entered: 11/20/2012)

Entry #2 • 2012-11-14
1
Pleading / Complaint

AFFIDAVIT OF SERVICE of Summons and Complaint. Impax Laboratories, Inc. served on 11/15/2012, answer due 12/6/2012. Service was accepted by Huong Nguyen, Senior Director of Intellectual Property. Document filed by Endo Pharmaceuticals Inc.; Grunenthal GMBH. (Sherman, Joshua) (Entered: 11/27/2012)

Entry #3 • 2012-11-27
1
Pleading / Complaint

AFFIDAVIT OF SERVICE of Summons and Complaint. Thorx Laboratories, Inc. served on 11/15/2012, answer due 12/6/2012. Service was accepted by Huong Nguyen, Senior Director of Intellectual Property. Document filed by Endo Pharmaceuticals Inc.; Grunenthal GMBH. (Sherman, Joshua) (Entered: 11/27/2012)

Entry #4 • 2012-11-27
1

NOTICE OF CASE ASSIGNMENT to Judge P. Kevin Castel. Judge Unassigned is no longer assigned to the case. (pgu) (Entered: 11/28/2012)

Entry #5 • 2012-11-28
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc